ECL vs FDMT · P/E 35, rev $4.01B vs rev $37.0K
Ecolab Inc (ECL) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
ECL currently screens at market cap $72.05B and trailing P/E 34.6. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the ECL and FDMT stock pages for the full models.
Not investment advice.